Emergent BioSolutions Inc.
US ˙ NYSE ˙ US29089Q1058

SecurityEBS / Emergent BioSolutions Inc.
InstitutionAmalgamated Bank
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Amalgamated Bank closes position in EBS / Emergent BioSolutions Inc.

On May 8, 2026 - Amalgamated Bank filed a 13F-HR form disclosing ownership of 0 shares of Emergent BioSolutions Inc. (US:EBS) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 1,639 shares of Emergent BioSolutions Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 0 -100.00 0
2026-02-05 2025-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 1,639 -204 -11.07 0 0.0001
2025-10-29 2025-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 1,843 0 0.00 0 0.0001
2025-08-04 2025-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 1,843 1,843 0 0.0001
2024-08-12 2024-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 0 -1,764 -100.00 0 0.0000
2024-04-23 2024-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 1,764 -2,707 -60.55 0 0.0000
2024-02-06 2023-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 4,471 -525 -10.51 0 0.0001
2023-11-08 2023-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 4,996 -13,640 -73.19 0 0.0001
2023-08-11 2023-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 18,636 -567 -2.95 0 0.0011
2023-05-02 2023-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 19,203 -606 -3.06 0 0.0017
2023-02-10 2022-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 19,809 -1,089 -5.21 0 -100.00 0.0021
2022-11-09 2022-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 20,898 62 0.30 439 -32.15 0.0042
2022-08-15 2022-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 20,836 -764 -3.54 647 -27.06 0.0060
2022-08-25 2022-03-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 21,600 -1,098 -4.84 887 -10.13 0.0069
2022-06-30 2022-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 21,600 -1,098 887 0.0070
2022-02-15 2021-12-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 22,698 -9,107 -28.63 987 -38.00 0.0073
2022-02-15 2021-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 22,698 -9,107 987 0.0073
2021-10-29 2021-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 31,805 -2,219 -6.52 1,592 -25.71 0.0134
2021-08-16 2021-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 34,024 27,206 399.03 2,143 238.55 0.0172
2021-05-13 2021-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 6,818 -627 -8.42 633 -5.10 0.0237
2021-02-12 2020-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 7,445 142 1.94 667 -11.66 0.0253
2020-10-30 2020-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 7,303 -241 -3.19 755 26.47 0.0328
2020-08-10 2020-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 7,544 -905 -10.71 597 22.09 0.0276
2020-05-13 2020-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 8,449 -161 -1.87 489 5.16 0.0120
2020-02-13 2019-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 8,610 128 1.51 465 4.97 0.0086
2019-11-13 2019-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 8,482 -145 -1.68 443 6.24 0.0093
2019-08-14 2019-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 8,627 1,408 19.50 417 14.25 0.0097
2019-05-15 2019-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 7,219 229 3.28 365 -11.84 0.0088
2019-02-15 2018-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 6,990 6,990 414 0.0117
2018-11-14 2018-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 0 -7,143 -100.00 0 -100.00
2018-07-18 2018-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 7,143 2,335 48.56 361 42.69 0.0088
2018-05-22 2018-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 4,808 -83 -1.70 253 11.45 0.0067
2018-02-13 2017-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 4,891 4,891 227 0.0061
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.